EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis

Zhuqing Li, Xiaoqiang Sun, Yanxin Wang, Feng Zhang, Li Wang, Chunbo Ai, Xu Zhang, Xuemei Yin, Chunlei Liu, Chao Li, Chengzhi Lu iD

Basic Research in Cardiology · 16.09.2025 · 120 (6) · 1225-1247

DOI: 10.1007/s00395-025-01138-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 16.09.2025. Verfasst von Zhuqing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin First Central Hospital, Tianjin, 300192, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Adenosine Triphosphate, Inflammasomes, Receptors, Purinergic P2X7. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Medical Health Science and Technology Project of Tianjin Municipal Health Commission, Natural Science Foundation of Tianjin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure with preserved ejection fraction (HFpEF) arises from intersecting comorbidities involving inflammation, metabolic stress, and sympathetic nervous system (SNS) activation. To mirror this complexity, we established a clinically oriented 3-hit mouse model combining advanced age, a high-fat diet, and chronic NOS inhibition with NG-Nitro-L-arginine methyl ester (L-NAME). We tested whether renal denervation (RDN) mitigates HFpEF by blunting SNS outflow and the ATP-P2X7-NLRP3 inflammasome axis, and in parallel probed the contribution of this pathway using pharmacologic and cellular approaches. 3-hit mice developed preserved ejection fraction with diastolic dysfunction, cardiomyocyte hypertrophy, interstitial fibrosis, impaired exercise capacity, and elevated inflammatory cytokines, accompanied by increased myocardial ATP, activation of P2X7/NLRP3 signaling, oxidative stress, and pyroptosis.RDN lowered systemic and myocardial norepinephrine, suppressed P2X7-NLRP3 inflammasome activation, reduced fibrosis and cardiomyocyte cross-sectional area, improved E/e′ and exercise capacity, and reduced oxidative stress and myocardial injury. In pharmacological intervention experiments, selective blockade with the P2X7 antagonist A438079 or the NLRP3 inhibitor MCC950 improved diastolic function and exercise capacity and attenuated myocardial fibrosis and cardiomyocyte hypertrophy. Complementary mechanistic studies in cardiomyocytes (H9c2 and primary neonatal rat cardiomyocytes) showed that ATP induced mitochondrial ROS accumulation, inflammasome activation, cytokine release, and cell injury, which were partially reversed by P2X7 knockdown or pharmacological antagonism. Together, these data validate a multi-hit HFpEF model and implicate an SNS-driven ATP-P2X7-NLRP3 axis as a potential therapeutic target. Both RDN and selective pathway inhibition improved diastolic function and attenuated ventricular remodeling, and inform future therapeutic strategies for HFpEF characterized by heightened sympathetic tone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinAdenosine TriphosphateInflammasomesReceptors, Purinergic P2X7KidneyHeart FailureStroke VolumeVentricular Function, LeftSympathectomyAnimalsMaleDisease Models, AnimalMice, Inbred C57BLMiceSignal TransductionRatsMyocytes, Cardiac

Stichwörter der Autor:innen

Adenosine triphosphateHeart failure with preserved ejection fractionNLRP3 inflammasomeP2X7 receptorRenal denervation

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinAdenosine TriphosphateInflammasomesReceptors, Purinergic P2X7Nlrp3 protein, mouseP2rx7 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Tianjin First Central Hospital, Tianjin, 300192, China.
  • Department of Physiology and Biomedical Engineering, Mayo Clinic, Scottsdale, AZ, 85259, USA.
  • First Central Hospital of Tianjin Medical University, Tianjin, 300070, China.
  • School of Medicine, Nankai University, Tianjin, 300071, China.
  • Department of Cardiology, Tianjin First Central Hospital, Tianjin, 300192, China. 874433965@qq.com.
  • Department of Cardiology, Tianjin First Central Hospital, Tianjin, 300192, China. 5020200072@nankai.edu.cn.

ORCID-Profile: Chengzhi Lu

Förderung

  • National Natural Science Foundation of China
  • Medical Health Science and Technology Project of Tianjin Municipal Health Commission
  • Natural Science Foundation of Tianjin
  • Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine

Zitieren

APA

Li, Z., Sun, X., Wang, Y., Zhang, F., Wang, L., Ai, C., Zhang, X., Yin, X., Liu, C., Li, C., & Lu, C. (2025). Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis. Basic Research in Cardiology, 120(6), 1225-1247. https://doi.org/10.1007/s00395-025-01138-5

Vancouver

Li Z, Sun X, Wang Y, Zhang F, Wang L, Ai C, et al. Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis. Basic Research in Cardiology. 2025;120(6):1225-1247. doi:10.1007/s00395-025-01138-5

BibTeX
@article{Li2025,
  author = {Li, Zhuqing and Sun, Xiaoqiang and Wang, Yanxin and Zhang, Feng and Wang, Li and Ai, Chunbo and Zhang, Xu and Yin, Xuemei and Liu, Chunlei and Li, Chao and Lu, Chengzhi},
  title = {Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis},
  journal = {Basic Research in Cardiology},
  year = {2025},
  volume = {120},
  number = {6},
  pages = {1225--1247},
  doi = {10.1007/s00395-025-01138-5}
}
Kostenlos starten →